Brain-controlled Spinal Cord Stimulation in Participants With Chronic Stroke for Lower and Upper Limb Rehabilitation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorEcole Polytechnique Fédérale de Lausanne

About this trial

The purpose of this clinical study is to evaluate the preliminary safety and effectiveness of using a cortical recording device (ECoG) combined with cervical and lumbar targeted epidural electrical stimulation (EES) of the spinal cord to restore voluntary motor functions of upper and lower limbs in participants with chronic stroke suffering from mobility impairment.

The goal is to establish a direct bridge between the motor intention of the participant and the spinal cord, which should not only improve or restore voluntary control of arm and leg movement and support immediate mobility, but also promote neurological recovery when combined with neurorehabilitation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Must be between 18-70 years old at the time of enrolment.

Must have suffered from a subcortical including brain stem stroke that occurred at least 9 months but not more than 10 years prior to enrolment.

Must have a score lower than 25 on the Fugl-Meyer upper-limb scale.

Must be able to stand with or without assistive device for 30 seconds.

Disqualifiers

Must not be pregnant or breast feeding (if applicable).

Must not have the intention to become pregnant during the study (if applicable).

Must not have any diseases and conditions that would increase the morbidity and mortality of the implantation surgery.

Must not have any mental instability, including a diagnosis of personality disorder, psychosis, substance abuse, or severe depression as assessed by the psychologist.

Trial design

Design model

Single group

Treatments tested in this trial

  • ARC-BSI Stroke system

    Device

    Implantation of a 64 channel - ECoG array over the sensory motor cortex of one side's upper and lower limbs, combined with an implantation of two 16 channel spinal cord stimulation system, one over the cervical region and one over the lumbar region. The decoded motor intentions are driving the implanted spinal cord stimulation system. Brain-controlled spinal cord stimulation is used for training and rehabilitation to recover voluntary movements.

Treatment groups

3 Participants
are divided into 1 treatment group
Group A: All participantsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Preliminary safety

Occurrence of Serious Adverse Events (SAE) and Adverse Events (AE) that are deemed related or possibly related to the procedure or to the ARC-BSI Stroke System.

Time frame
From enrollment until End of the Study timepoint (at 5 years)

Secondary outcomes

1

Fugl-Meyer Assessment Lower Extremities

A performance-based measure used to assess motor functioning, balance, sensation, joint range of motion and joint pain in upper and lower limbs of stroke patients.

Time frame
Pre-implantation: Baseline (B) Post-implantation (counting from first surgery) :6-Months measures (M6), 1-Year Measures (Y1), then Yearly Measures until 5 years (Y2, Y3, Y4 and Y5). All the timepoint Measures last 1 to 2 weeks.
2

10 Meters Walk Test (10MWT)

Clinical measure to assess walking speed (in m/s) over 10 meters.

Time frame
Pre-implantation: Baseline (B) Post-implantation (counting from first surgery) :6-Months measures (M6), 1-Year Measures (Y1), then Yearly Measures until 5 years (Y2, Y3, Y4 and Y5). All the timepoint Measures last 1 to 2 weeks.
3

6 Minute Walk Test (6MWT):

Submaximal test to assess endurance during 6 minutes of walking.

Time frame
Pre-implantation: Baseline (B) Post-implantation (counting from first surgery) :6-Months measures (M6), 1-Year Measures (Y1), then Yearly Measures until 5 years (Y2, Y3, Y4 and Y5). All the timepoint Measures last 1 to 2 weeks.
4

Timed Up and Go (TUG):

Timed test of functional mobility (stand-up, walk, turn around, sit-down)

Time frame
Pre-implantation: Baseline (B) Post-implantation (counting from first surgery) :6-Months measures (M6), 1-Year Measures (Y1), then Yearly Measures until 5 years (Y2, Y3, Y4 and Y5). All the timepoint Measures last 1 to 2 weeks.

Other outcomes

1

Stroke-Specific Quality of Life (SS-QOL)

The SS-QOL assesses health-related quality of life specific to stroke survivors. It considers different areas including behavior, cognition, functional mobility, language, negative affect, personality, quality of life, social relationships, and upper extremity function. This questionnaire will help the investigators to evaluate the areas in which the participant is most affected and determine if there is an evolution during the study.

Time frame
Baseline; monthly for up to 1 year during the Main Study phase; and every 3 months for up to 5 years during the Optional Study Extension phase
2

Psychosocial Impact of Assistive Device Scale (PIADS)

The PIADS is a 26-item, self-report questionnaire designed to assess the effects of an assistive device on functional independence, well-being, and quality of life

Time frame
Monthly for up to 1 year during the Main Study phase; and every 3 months for up to 5 years during the Optional Study Extension phase
3

Stroke Impact Scale (SIS)

A self-report questionnaire that evaluates disability and health-related quality of life after stroke. It assesses different areas including activities of daily living, cognition, communication, depression, function mobility, gait, general health, life participation, quality of life, social relationships, social support, and upper extremity function.

Time frame
Baseline; monthly for up to 1 year during the Main Study phase; and every 3 months for up to 5 years during the Optional Study Extension phase
4

Goal Attainment Scaling (GAS)

A method of scoring the extent to which patient's individual goals are achieved during intervention. In effect, each patient has their own outcome measure, but this is scored in a standardized way to allow statistical analysis.

Time frame
Pre-implantation: Baseline (B) Post-implantation (counting from first surgery) :6-Months measures (M6), 1-Year Measures (Y1), then Yearly Measures until 5 years (Y2, Y3, Y4 and Y5).

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ecole Polytechnique Fédérale de Lausanne

Lead sponsor

Centre Hospitalier Universitaire Vaudois

Sponsor institution